BioStock: Xintela highlights the unique properties of XSTEM
Biopharma company Xintela develops stem cell products with therapeutic properties aiming to treat diseases that currently lack effective treatment options. The company´s stem cells stand out from others through a selection step in the production process that provides quality-assured, homogenous and pure stem cell preparations. BioStock talked to Lucienne Vonk, Director Musculoskeletal Diseases at Xintela, about the benefits of the company’s stem cell products.Read the full article at biostock.se: https://www.biostock.se/en/2023/05/xintela-highlights-the-unique-properties-of-xstem/